Yusuke Murakawa

Title: Yusuke Murakawa: Innovator in Pharmaceutical Preparations

Introduction

Yusuke Murakawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release preparations. With a total of 2 patents to his name, Murakawa's work is recognized for its innovative approach to drug formulation.

Latest Patents

Murakawa's latest patents include a sustained-release preparation that contains pioglitazone or a salt thereof as an active ingredient. This preparation demonstrates superior sustainability, showing a dissolution ratio of pioglitazone of an average of 25-58% at the 2-hour time point and 60-100% at the 4-hour time point, according to the 50 rpm USP Paddle Method using a pH 2.0 KCl/HCl buffer at 37°C as a test solution. Another significant patent involves a solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile, which serves as a pharmaceutically active ingredient.

Career Highlights

Yusuke Murakawa is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda has been instrumental in advancing pharmaceutical formulations that enhance drug delivery and efficacy.

Collaborations

Murakawa has collaborated with notable colleagues such as Yutaka Tanoue and Yumiko Ishii. These collaborations have contributed to the innovative research and development efforts within the pharmaceutical sector.

Conclusion

Yusuke Murakawa's contributions to pharmaceutical innovations highlight his expertise and commitment to improving drug formulations. His patents reflect a dedication to enhancing patient care through advanced pharmaceutical technologies.